141 related articles for article (PubMed ID: 8987163)
1. Inhibition of thrombin by hirudin genetically fused to wild-type or mutant antithrombin.
Syed S; Kelly KE; Sheffield WP
Thromb Res; 1996 Dec; 84(6):419-29. PubMed ID: 8987163
[TBL] [Abstract][Full Text] [Related]
2. Potent antithrombin activity and delayed clearance from the circulation characterize recombinant hirudin genetically fused to albumin.
Syed S; Schuyler PD; Kulczycky M; Sheffield WP
Blood; 1997 May; 89(9):3243-52. PubMed ID: 9129029
[TBL] [Abstract][Full Text] [Related]
3. A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo.
Sheffield WP; Eltringham-Smith LJ; Gataiance S; Bhakta V
Thromb Haemost; 2009 May; 101(5):867-77. PubMed ID: 19404540
[TBL] [Abstract][Full Text] [Related]
4. Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition.
Roddick LA; Bhakta V; Sheffield WP
BMC Biochem; 2013 Nov; 14():31. PubMed ID: 24215622
[TBL] [Abstract][Full Text] [Related]
5. Prolonged in vivo anticoagulant activity of a hirudin-albumin fusion protein secreted from Pichia pastoris.
Sheffield WP; Smith IJ; Syed S; Bhakta V
Blood Coagul Fibrinolysis; 2001 Sep; 12(6):433-43. PubMed ID: 11555696
[TBL] [Abstract][Full Text] [Related]
6. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
[TBL] [Abstract][Full Text] [Related]
7. Construction and in vitro testing of a novel fab-hirudin-based fusion protein that targets fibrin and inhibits thrombin in a factor xa-dependent manner.
Peter K; Gupta A; Nordt T; Bauer S; Runge MS; Bode C
J Cardiovasc Pharmacol; 2003 Aug; 42(2):237-44. PubMed ID: 12883328
[TBL] [Abstract][Full Text] [Related]
8. A fusion protein with improved thrombolytic effect and low bleeding risk.
Wang X; Zhang G; Wang L; Zhang Q; Qin Y; Wu C; Yu A
Thromb Haemost; 2009 Dec; 102(6):1194-203. PubMed ID: 19967151
[TBL] [Abstract][Full Text] [Related]
9. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
[TBL] [Abstract][Full Text] [Related]
10. Potential advantages of direct-acting thrombin inhibitors.
Philippides GJ; Loscalzo J
Coron Artery Dis; 1996 Jul; 7(7):497-507. PubMed ID: 8913677
[No Abstract] [Full Text] [Related]
11. [Research progress in hirudin fusion protein--review].
Zhang CL; Yu AP; Jin JD; Wu CT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):215-8. PubMed ID: 17490558
[TBL] [Abstract][Full Text] [Related]
12. Display of functional thrombin inhibitor hirudin on the surface of phage M13.
Wirsching F; Opitz T; Dietrich R; Schwienhorst A
Gene; 1997 Dec; 204(1-2):177-84. PubMed ID: 9434182
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of heparin and hirudin on thrombin binding to the normal and the de-endothelialized rabbit aorta in vitro.
Hatton MW; Moar SL
Thromb Haemost; 1991 Aug; 66(2):208-12. PubMed ID: 1771613
[TBL] [Abstract][Full Text] [Related]
14. Effect of heparin on the interaction between thrombin and hirudin.
Stone SR; Hofsteenge J
Eur J Biochem; 1987 Dec; 169(2):373-6. PubMed ID: 3691497
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of recombinant hirudins.
Stürzebecher J; Walsmann P
Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
[TBL] [Abstract][Full Text] [Related]
16. Use of fragments of hirudin to investigate thrombin-hirudin interaction.
Dennis S; Wallace A; Hofsteenge J; Stone SR
Eur J Biochem; 1990 Feb; 188(1):61-6. PubMed ID: 2180697
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-hirudin complex stability: a comparison with the thrombin-antithrombin III complex.
Römisch J; Pâques EP
Blood Coagul Fibrinolysis; 1991 Oct; 2(5):643-6. PubMed ID: 1782334
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoassay for the detection of active-site specific thrombin inhibitors in biological fluids. II. Heparin affects the binding of hirudin to alpha-thrombin.
Lackmann M; Geczy CL
Thromb Res; 1991 Sep; 63(6):609-16. PubMed ID: 1780805
[TBL] [Abstract][Full Text] [Related]
19. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis.
Mirshahi M; Soria J; Soria C; Faivre R; Lu H; Courtney M; Roitsch C; Tripier D; Caen JP
Blood; 1989 Aug; 74(3):1025-30. PubMed ID: 2502207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
